Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Revive Therapeutics's operating assets for the quarter that ended in Mar. 2026 was $0.20 Mil. Revive Therapeutics's operating liabilities for the quarter that ended in Mar. 2026 was $3.09 Mil. Revive Therapeutics's Total Assets for the quarter that ended in Dec. 2025 was $0.19 Mil. Therefore, Revive Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was -15.29.
Revive Therapeutics Scaled Net Operating Assets Related Terms
Revive Therapeutics Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Revive Therapeutics's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revive Therapeutics Scaled Net Operating Assets Chart
RVVTF vs ZTS, UTHR: Scaled Net Operating Assets Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revive Therapeutics Scaled Net Operating Assets vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Revive Therapeutics's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of -15.29 mean?
Revive Therapeutics (RVVTF) has a Scaled Net Operating Assets of -15.29 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Revive Therapeutics and its competitors.
Is Revive Therapeutics' Scaled Net Operating Assets too high?
Revive Therapeutics' current Scaled Net Operating Assets is -15.29.
How does Revive Therapeutics' Scaled Net Operating Assets compare to ZTS and UTHR?
Revive Therapeutics' Scaled Net Operating Assets of -15.29 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Revive Therapeutics and its competitors. Revive Therapeutics's current Scaled Net Operating Assets is -15.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revive Therapeutics stock overvalued right now?
Revive Therapeutics (RVVTF) has a current Scaled Net Operating Assets of -15.29. The current Scaled Net Operating Assets is -15.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Revive Therapeutics (RVVTF), the current Scaled Net Operating Assets is -15.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. The company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVVTF has been successfully added to your 